Both natural and surgical menopause are closely linked to the development of kidney stones.

Published Date: 17 Feb 2023

A recent study published in the Annals of Epidemiology found that diabetes and postmenopausal surgery are associated with kidney stone disease (KSD).

Read Full News

Latest News

Robotic Surgery May Help Restore Urine Control in Women

A robot-assisted procedure placing an artificial urinary sphincter may help women with stress incontinence achieve little or no urine leakage.

Many Men With LUTS Could Be Candidates to Stop Alpha-Blocker Treatment

— Novel N-of-1 study design showed minimal treatment effect for 11 of 30 patients

Advancing Evidence-Based Care for Veterans With mHSPC: Pathways, Personalization, and Team-Based Strategies

Advancing Evidence-Based Care for Veterans With mHSPC: Pathways, Personalization, and Team-Based Strategies

Latest Clinical Data for Emerging Combination Strategies in mHSPC

Latest Clinical Data for Emerging Combination Strategies in mHSPC

Redefining MIBC Standards: Multidisciplinary Insights on Optimizing Immunotherapy-Based Combinations

Redefining MIBC Standards: Multidisciplinary Insights on Optimizing Immunotherapy-Based Combinations

Towards Personalized Treatment in mHSPC: Latest Evidence for Biomarker-Targeted Therapies and Multidisciplinary Toxicity Management

Towards Personalized Treatment in mHSPC: Latest Evidence for Biomarker-Targeted Therapies and Multidisciplinary Toxicity Management

Todays Updates

Despite Medicare Coverage, Cancer Genomic Testing Still Low

Medicare coverage of next-generation sequencing may have spurred an increase in the number of patients receiving genomic tests. But uptake remains low.

Todays Updates

Despite Medicare Coverage, Cancer Genomic Testing Still Low

Medicare coverage of next-generation sequencing may have spurred an increase in the number of patients receiving genomic tests. But uptake remains low.

Latest News

A robot-assisted procedure placing an artificial urinary sphincter may help women with stress incontinence achieve little or no urine leakage.

— Novel N-of-1 study design showed minimal treatment effect for 11 of 30 patients

Advancing Evidence-Based Care for Veterans With mHSPC: Pathways, Personalization, and Team-Based Strategies

Latest Clinical Data for Emerging Combination Strategies in mHSPC

Redefining MIBC Standards: Multidisciplinary Insights on Optimizing Immunotherapy-Based Combinations

Towards Personalized Treatment in mHSPC: Latest Evidence for Biomarker-Targeted Therapies and Multidisciplinary Toxicity Management

News All Time

Evidence Mounts for Darolutamide Plus ADT in Hormone-Sensitive Prostate Cancer

U.S. study supports findings from a global trial using an external control arm

He Inserted a Cable in His Penis. 10 Years Later, He Needed Surgery.

Patient in his 60s eventually developed sepsis

Erectile Dysfunction May Predispose Older Men to Multiple Types of Substance Abuse

Significantly higher risk of sedative, opioid, cocaine abuse compared with no ED diagnosis

GLP-1 Drugs Linked to Significant Boost in Testosterone Levels for Men

Weight loss likely not the only reason for improvement, researcher says

Tibial Nerve Stimulation for Overactive Bladder Tied to Better Quality of Life

But main results from sham-controlled trial still outstanding

No Prostate Cancer Survival Benefit With More Extensive Lymph Node Assessment

Long-term follow-up consistent with earlier report, a hint of benefit in high-grade disease

Stoking Sexual Arousal and Desire: GLP-1s, Nerve Stimulation, 'Scream Cream'

GLP-1 agonists not helpful, may be harmful whereas neural, topical strategies often useful

Prostate Cancer Drug Linked to Lower Risk of Cognitive Decline

Darolutamide offers "an option for preserving cognitive health" in advanced disease, expert says

The Blind Spot in Bladder Cancer Care: What Patients Don't Say

Patients and urologists are not always aligned on what the treatment experience will be like

In Search of Effective Treatment for Premature Ejaculation: 'I Really Have No Idea'

Lack of high-level evidence has hindered treatment development, but some patients do improve

FDA OKs Immunotherapy-BCG Combo for High-Risk Bladder Cancer

Combination significantly improved disease-free survival in phase III trial

Practice-Changing Trial in Prostate Cancer Shows Benefits of Perioperative Therapy

ADT plus apalutamide before and after surgery significantly improved metastasis-free survival

Treatment Intensification Slows Metastatic Hormone-Sensitive Prostate Cancer

Talazoparib plus enzalutamide reduces progression risk by 50% in men with DNA repair alterations

Combating Cancer-Related Fatigue: Yoga, Bupropion, Exercise Plus Methylphenidate

Significant improvement with yoga and the atypical antidepressant

FDA's 'Big Dick Energy!' Warning; UHC Retreats on Prior Auth; Nurses Beat Ebola

Health news and commentary gathered by MedPage Today staff

FDA OKs Inflatable Penile Prosthesis for Erectile Dysfunction

Appearance and performance designed to emulate a natural erection

Recommended News For You

Investigations may result in novel combination therapies for early-stage lung cancers.

Durvalumab Wins FDA Approval in Limited-Stage SCLC

Could semaglutide be used to treat addiction in addition to obesity?

Race, Geography Linked to Gaps in Prostate Cancer Care

Is global cancer care losing its human touch?

Even after a partial ban, asbestos is still used and is a deadly carcinogen, according to the EPA.

Congress Ditched Fix to Medicare Doc Pay Cut in Skinny Budget Bill

Recommended Articles For You

Improving TIVAP Use: Review of Standardization and Optimization Practices 

Targeting Oncology: Expanding Combinatorial Strategies by 2025 

Florinef: Understanding Its Uses and Side Effects  

Exploring New Solutions for MCV Low: Unlocking the Potential for Improved Health 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Mosunetuzumab in Follicular Lymphoma: Durable Responses and Manageable Safety

2.

As EGFR internalization is decreased, BUB1 controls EGFR signaling.

3.

Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation

4.

Low Income, Education Tied to Depression in Older Adults

5.

In Higher-Risk MDS, CMML, All-Oral Therapy Has Promise.

1.

Bridging Disciplines: Medical Oncology vs Surgical Oncology in the Era of Multidisciplinary Cancer Care

2.

Next-Gen CAR Cell Therapies in Oncology: Frontiers in Solid Tumors & Hematologic Malignancies

3.

Next-Generation Sequencing in Oncology: Unlocking the Future of Precision Medicine

4.

Unlocking the Key to Treating Lymphoma: New Innovations in Cancer Research

5.

Personalizing Cancer Care: Microbiome Advances, Challenges, and Future Directions

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI

2.

Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment

3.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV

4.

Managing CNS diseases at the point of diagnosis in ALK + NSCLC

5.

Navigating the Complexities of Ph Negative ALL - Part XV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot